Free Trial

Fox Run Management L.L.C. Invests $1.04 Million in Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels logo with Construction background
Remove Ads

Fox Run Management L.L.C. bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 87,573 shares of the construction company's stock, valued at approximately $1,040,000. Fox Run Management L.L.C. owned 0.11% of Aspen Aerogels as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Quest Partners LLC boosted its holdings in Aspen Aerogels by 263.3% during the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock worth $205,000 after buying an additional 5,361 shares in the last quarter. Intech Investment Management LLC acquired a new stake in shares of Aspen Aerogels during the third quarter worth $497,000. Charles Schwab Investment Management Inc. raised its position in shares of Aspen Aerogels by 204.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company's stock worth $14,106,000 after purchasing an additional 342,253 shares during the period. Algert Global LLC lifted its holdings in shares of Aspen Aerogels by 60.2% during the third quarter. Algert Global LLC now owns 127,764 shares of the construction company's stock valued at $3,538,000 after purchasing an additional 48,007 shares during the last quarter. Finally, Penserra Capital Management LLC acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at $1,342,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Craig Hallum cut their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday, February 14th. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Barclays lowered their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 19th. Finally, Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and a consensus target price of $19.11.

Remove Ads

Read Our Latest Report on ASPN

Aspen Aerogels Stock Performance

Shares of ASPN traded down $0.11 on Thursday, reaching $6.94. 1,038,768 shares of the stock traded hands, compared to its average volume of 1,805,357. The firm has a market cap of $569.40 million, a price-to-earnings ratio of 43.35 and a beta of 2.28. Aspen Aerogels, Inc. has a 12 month low of $6.60 and a 12 month high of $33.15. The stock's 50-day moving average price is $9.28 and its 200-day moving average price is $14.94. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads